N-Butyldeoxynojirimycin (CAS 72599-27-0): Your Trusted Supplier for Lysosomal Storage Disorder Treatment
Discover a leading manufacturer and supplier of high-purity N-Butyldeoxynojirimycin (CAS 72599-27-0). We provide critical pharmaceutical intermediates essential for treating lysosomal storage disorders. Secure your supply chain with our reliable global distribution and competitive pricing for Miglustat.
Get a Quote & SampleYour Source for High-Quality Pharmaceutical Intermediates
N-Butyldeoxynojirimycin
As a premier chemical manufacturer and supplier in China, we offer N-Butyldeoxynojirimycin (CAS 72599-27-0), also known as Miglustat. This crucial pharmaceutical intermediate acts as a potent glucosylceramide synthase inhibitor, vital for managing conditions like Type I Gaucher disease and Niemann-Pick disease type C. We ensure product purity exceeding 98%, backed by robust quality control. Partner with us for a stable, cost-effective supply of this essential compound for your R&D and manufacturing needs.
- Source High-Purity N-Butyldeoxynojirimycin (CAS 72599-27-0) for Pharmaceutical Development
- Reliable Global Supplier of Miglustat for Lysosomal Storage Disorder Therapy
- Competitive Pricing on Bulk Purchases of N-Butyldeoxynojirimycin for Manufacturers
- Secure Your Supply Chain with our Dependable Manufacturer in China for NB-DNJ
Why Partner With Us for Your N-Butyldeoxynojirimycin Needs?
Uncompromising Purity and Quality
Our N-Butyldeoxynojirimycin (CAS 72599-27-0) consistently meets stringent purity standards (>98%), ensuring optimal performance in pharmaceutical formulations and research applications. We are a dedicated manufacturer committed to quality assurance.
Global Supply Chain Expertise
As a leading supplier, we efficiently manage global logistics, ensuring timely delivery of your required N-Butyldeoxynojirimycin quantities. We cater to diverse customer needs, from research labs to large-scale pharmaceutical manufacturers seeking a reliable source.
Cost-Effective Manufacturing Solutions
Leverage our competitive pricing and bulk purchasing options for N-Butyldeoxynojirimycin (Miglustat). We aim to reduce your procurement costs while maintaining product integrity, making us the preferred manufacturer for businesses worldwide.
Key Applications of N-Butyldeoxynojirimycin
Treatment of Lysosomal Storage Disorders
N-Butyldeoxynojirimycin is a critical active pharmaceutical ingredient (API) for the treatment of genetic disorders characterized by the accumulation of glycosphingolipids, such as Type I Gaucher disease. Its mechanism as a glucosylceramide synthase inhibitor is well-established.
Glycosphingolipid Synthesis Inhibition
This compound functions as an enzyme inhibitor, specifically targeting glucosylceramide synthase. This inhibition is key to reducing the biosynthesis of glycosphingolipids, addressing underlying metabolic imbalances in various disease states. Buy this essential research chemical to explore its potential.
Pharmaceutical Research and Development
Researchers rely on high-quality N-Butyldeoxynojirimycin for in vitro and in vivo studies related to lipid metabolism and genetic diseases. As a dedicated supplier, we support your R&D efforts with consistent product availability and detailed technical data.
Active Pharmaceutical Ingredient (API)
N-Butyldeoxynojirimycin serves as an API in approved therapies. Pharmaceutical companies seeking a reliable manufacturer for large-scale production can depend on our expertise and production capacity for this vital compound.